Hexoskin's CEO Pierre-Alexandre Fournier was invited to speak at a seminar co-hosted by Stanford eWEAR and Stanford Medicine's Precision Health and Integrated Diagnostics Center (PHIND) held online on December 1st. The seminar covered the capabilities of wearable technologies and Hexoskin to support the early detection of diseases such as the COVID-19 onset.
With over 100 Scientific Publications and validations, Hexoskin has the only clinically validated biometric garment which provides continuous monitoring of numerous and unique physiological parameters. It is an enabling technology for telehealth use cases, such as remote patient monitoring, at-home cardiovascular and pulmonary rehabilitation, and post-acute care.
Along with its smart clothing, Hexoskin offers a unique set of high-resolution biometric data that can continuously monitor activity, sleep, cardiac and respiratory data. Projects in fields such as cardiology, respiratory, behavioral and physiological psychology, biofeedback research, sleep research, and health will be presented during the seminar.
The Hexoskin Connected Health Platform provides researchers with accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, annotate, analyze, and export raw & processed health data. Data extraction tools allow access to the raw data with time series for machine learning and artificial intelligence projects, making Hexoskin and excellent solution to collect high-resolution data quickly to deliver projects and results. Watch it online today!
Since the beginning of March, Hexoskin has been working with governements and health systems in the US and Canada to define actions to support healthcare services during the COVID-19 response.
We are currently putting in place patient monitoring programs in hospitals and at home for COVID-19 patients. These projects are important to support telehealth services, but also to gather data for medical research and manage the public response to the virus. We are now working on onboarding our first COVID-19 patients.
The data collected will also be used to develop AI/machine learning software to better assess the risk of COVID-19 patients recovering at home. Hexoskin biometric shirts can continuously measure respiration effort in addition to cardiac activity, which provides unique data to understand the evolution of the disease and its effects on lung function.
We are also working with health systems on rapidly setting up programs to ensure the continuity of care for patients currently enrolled in cardiac and pulmonary rehabilitation programs with online tools.
We understand that hospitals are currently focused 100% on hospitalized patients, that's why Hexoskin is setting up telehealth teams of its own and offering these resources to support these programs and complement health systems' resources.
If you are looking for help for telehealth programs or COVID-19 home monitoring programs please contact us today: email@example.com / 1-888-887-2044
Montreal-based @Hexoskin has created a high-tech shirt capable of monitoring #COVID19 patients from home. This #technology is helping to reduce the burden on healthcare facilities and workers as we fight COVID-19.— Invest in Canada (@invest_canada) June 18, 2020
Learn more: https://t.co/QbVXZ3KQVr#CanadaResilient pic.twitter.com/oQmWAJNChH
Health care of tomorrow, today: How artificial intelligence is fighting the current, and future, #COVID19 pandemic: https://t.co/AxwZbQNFCF ft @envisagenics @Hexoskin @AuransaInc @healx #ai #machinelearning #medtwitter via @thehill— Alliance for Artificial Intelligence in Healthcare (@theaaih) April 20, 2020
Don't let #COVID19 be in the way of your #clinicaltrials. Hexoskin can support your virtual clinical trials needs (logistics, phone/video support and follow-ups, equipment, etc.). firstname.lastname@example.org / 1-888-887-2044— Hexoskin - Sensors & AI (@Hexoskin) March 31, 2020